» Articles » PMID: 31176801

Bronchiectasis and Cough: An Old Relationship in Need of Renewed Attention

Overview
Specialty Pulmonary Medicine
Date 2019 Jun 10
PMID 31176801
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Bronchiectasis is an increasingly recognised respiratory condition with limited therapeutic options and a complex spectrum of clinical manifestations that invariably includes chronic cough. As the primary presentation of bronchiectasis in most cases, chronic cough and its mechanistic underpinnings are of central importance but remain poorly understood in this setting. Bronchiectasis is also increasingly identified as an underlying cause of chronic cough highlighting the interrelationship between the two conditions that share overlapping clinical features. Several therapeutic approaches have illustrated positive effects on bronchiectasis-associated cough, however, more focused treatment of heterogeneous cough subtypes may yield better outcomes for patients. A current challenge is the identification of bronchiectasis and cough endophenotypes that may allow improved patient stratification and more targeted therapeutic matching of the right treatment to the right patient. Here we discuss the complex disease phenotypes of bronchiectasis and their interrelationship with cough while considering current and emerging treatment options. We discuss some key cough promoters in bronchiectasis including infection, allergy and immune dysfunction.

Citing Articles

Nationwide study of chronic codeine use and its impact on cough related diseases in South Korea.

An T, Lee Y, Joh J, Myong J Sci Rep. 2024; 14(1):30225.

PMID: 39632868 PMC: 11618306. DOI: 10.1038/s41598-024-80506-y.


Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects.

Spinou A, Lee A, ONeil B, Oliveira A, Shteinberg M, Herrero-Cortina B Eur Respir Rev. 2024; 33(174).

PMID: 39477356 PMC: 11522970. DOI: 10.1183/16000617.0087-2024.


Lung microbiome: new insights into bronchiectasis' outcome.

Azoicai A, Lupu A, Alexoae M, Starcea I, Mocanu A, Lupu V Front Cell Infect Microbiol. 2024; 14:1405399.

PMID: 38895737 PMC: 11183332. DOI: 10.3389/fcimb.2024.1405399.


Hot topics and current controversies in non-cystic fibrosis bronchiectasis.

Severiche-Bueno D, Gamboa E, Reyes L, Chotirmall S Breathe (Sheff). 2019; 15(4):286-295.

PMID: 31803263 PMC: 6885332. DOI: 10.1183/20734735.0261-2019.

References
1.
Chung K . Advances in mechanisms and management of chronic cough: The Ninth London International Cough Symposium 2016. Pulm Pharmacol Ther. 2017; 47:2-8. DOI: 10.1016/j.pupt.2017.02.003. View

2.
Niimi A, Torrego A, Nicholson A, Cosio B, Oates T, Chung K . Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol. 2005; 116(3):565-70. DOI: 10.1016/j.jaci.2005.07.010. View

3.
Pasteur M, Bilton D, Hill A . British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010; 65 Suppl 1:i1-58. DOI: 10.1136/thx.2010.136119. View

4.
Mandal P, Chalmers J, Graham C, Harley C, Sidhu M, Doherty C . Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial. Lancet Respir Med. 2014; 2(6):455-63. DOI: 10.1016/S2213-2600(14)70050-5. View

5.
Rosen M . Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl):122S-131S. DOI: 10.1378/chest.129.1_suppl.122S. View